Passage Bio, Inc. (PASG)
$3.69-2.38%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $12M
- Beta
- 1.43
- P/E (TTM)
- -0.36
- Short % float
- 3.15%
- Days to cover
- 3.7
- SI change
- -6.4%
- 1W
- -10.44%
- 1M
- -26.05%
- vs SPY 1W
- -11.60%
- vs SPY 1M
- -29.04%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PASG?
- LOPJLB’s latest quantitative signal on Passage Bio, Inc. (PASG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PASG in?
- Passage Bio, Inc. (PASG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Passage Bio, Inc. (PASG) do?
- Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to treat infantile GM1 gangliosidosis by utilizing a proprietary AAVhu68 capsid to deliver a functional GLB1 gene, which codes for the lysosomal acid beta-galactosidase enzyme, to both the brain and peri…